Klinik fanlar yilnomasi Volume 2 Issue 2 (2025)

FEATURES OF LIPID METABOLISM DISORDERS IN PATIENTS WHO HAVE EXPERIENCED COVID-19 AND ITS CORRECTION WITH ROZUVASTATIN (literature review)

Хайруллаева Г.С

Read at source PDF

Abstract

The purpose of this overview scientific work is to analyze the clinical and pathogenetic mechanisms of lipid metabolism disorders in patients who have undergone COVID-19 and to evaluate the effectiveness of treatment with rozuvastatin. SARS-CoV-2 has a systemic effect on metabolic processes, including lipid metabolism, manifested by the development of dyslipidemia, which contributes to an increased cardiovascular risk. The article examines the mechanisms of these disorders, their relationship with post-COVID syndrome, and presents data on the positive effects of rosevastatin on lipid profile and inflammatory markers in such patients.

dyslipidemia, rosuvastatin, COVID-19, lipid metabolism, metabolic processдислипидемия, розувастатин, COVID-19, липидный обмен, метоболический процессдислипидемия, розувастатин, COVID-19, липид алмашинуви, метоболик жараён

Metadata source: the journal's OAI-PMH archive · Sindex does not store the full text; it links to the source.

Cite

APA 7 
Хайруллаева Г.С (2025). FEATURES OF LIPID METABOLISM DISORDERS IN PATIENTS WHO HAVE EXPERIENCED COVID-19 AND ITS CORRECTION WITH ROZUVASTATIN (literature review). Klinik fanlar yilnomasi, 2(2).
GOST R 7.0.5 
Хайруллаева Г.С FEATURES OF LIPID METABOLISM DISORDERS IN PATIENTS WHO HAVE EXPERIENCED COVID-19 AND ITS CORRECTION WITH ROZUVASTATIN (literature review) // Klinik fanlar yilnomasi. 2025. Т. 2. № 2.
BibTeX 
@article{г.с2025,
  author  = {Хайруллаева Г.С},
  title   = {FEATURES OF LIPID METABOLISM DISORDERS IN PATIENTS WHO HAVE EXPERIENCED COVID-19 AND ITS CORRECTION WITH ROZUVASTATIN (literature review)},
  journal = {Klinik fanlar yilnomasi},
  year    = {2025},
  volume  = {2},
  number  = {2}
}
RIS 
TY  - JOUR
AU  - Хайруллаева Г.С
TI  - FEATURES OF LIPID METABOLISM DISORDERS IN PATIENTS WHO HAVE EXPERIENCED COVID-19 AND ITS CORRECTION WITH ROZUVASTATIN (literature review)
JO  - Klinik fanlar yilnomasi
PY  - 2025
VL  - 2
IS  - 2
ER  -